LISATA THERAPEUTICS, INC. — Director's Dealing 2020

Jan 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CALADRIUS BIOSCIENCES, INC. (CLBS)
CIK: 0000320017
Period of Report: 2020-01-13

Reporting Person: KLOSK STEVEN M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-13	Restricted Stock Units	A	18292	$3.28	Acquired	48225	Direct

Footnotes

F1: Represents 18,292 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 13, 2021.

F2: Includes 18,292 unvested restricted stock units.